RegisterLogin

VVD-699

CAT: 0804-HY-173405-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-173405-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VVD-699 is a covalent RAS-PI3K inhibitor. VVD-699 covalently binds to cysteine 242 in the RAS binding domain of PI3K p110α, thereby blocking the ability of RAS to activate PI3K activity. VVD-699 is able to inhibit the growth of RAS-mutated and HER2-overexpressing tumors. VVD-699 can be used to study cancers associated with RAS mutations (e.g., H358 lung cancer cells, A549 cells, FaDu cells) [1].
CAS Number
[3055319-82-6]
UNSPSC
12352005
Target
PI3K; Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
COC1=CC(C2=C(Cl)C=CC=C2)=C(S(N3CC[C@](C(N[C@@H](/C=C\S(C)(=O)=O)C)=O)(F)C[C@H]3C)(=O)=O)C=C1
Molecular Formula
C25H30ClFN2O6S2
Molecular Weight
573.10
References & Citations
[1]Klebba JE, et al. Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2. bioRxiv [Preprint]. 2024 Dec 20:2024.12.17.629001. PMCID: PMC11703231.1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-151385-01VVD-118313
HY-176811VVD-442
HY-169766VVD 065
HY-159641-01VVD-130037
HY-158116-01VVD-214
HY-176812VVD-849
HY-151385A-01(R, R) -VVD-118313
HY-W952810CRBN ligand-699
HY-R03724-01Mmu-miR-6996-3p mimic
HY-RI03722-01Mmu-miR-6995-3p inhibitor

Alternative Products

CatalogName
T206721-01VVD-699
M37603-01VVD-130037
T62361-01VVD-118313
T212213-01VVD-849
BA3955-5.1VVD-214
T212418-01VVD-442
JH916906VVD-133214
T212577-01VVD 065
MBS131645-01LCI-699
C03313-01VVD-130037 (BAY-3605349)

Popular Products